Evidence map›Paper›PMID 26692098›Full record

ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2016

Decreased long noncoding RNA MIR31HG is correlated with poor prognosis and contributes to cell proliferation in gastric cancer.

Feng-Qi Nie, Shijie Ma, Min Xie, Yan-Wen Liu, Wei De, Xiang-Hua Liu

Abstract read
PubMed Publisher
In one paragraph

Article in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Host gene and its guest: short story about relation of long-noncodingReports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2023
    Review
  7. Long Non-Coding RNAInternational journal of molecular sciences · 2022
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. LncRNAInternational journal of molecular sciences · 2021
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Feng-Qi NieDepartment of Oncology, Second Affiliated Hospital, Nanjing Medical University, Nanjing, People's Republic of China.
Shijie MaDepartment of Gastroenterology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, People's Republic of China.
Min XieDepartment of Biochemistry and Molecular Biology, Nanjing Medical University, 210029, Nanjing, People's Republic of China.
Yan-Wen LiuDepartment of Biochemistry and Molecular Biology, Nanjing Medical University, 210029, Nanjing, People's Republic of China.
Wei DeDepartment of Biochemistry and Molecular Biology, Nanjing Medical University, 210029, Nanjing, People's Republic of China.
Xiang-Hua LiuDepartment of Biochemistry and Molecular Biology, Nanjing Medical University, 210029, Nanjing, People's Republic of China. liuxianghua@njmu.edu.cn.
Nanjing Medical University · CNSecond Affiliated Hospital of Nanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long noncoding RNAs (lncRNAs) are emerging as key regulators governing fundamental biological processes, and their disorder expression involves in the development of several human cancers. MIR31HG, an lncRNA located in 9p21.3 and 2166 bp in length, has been found to be upregulated in breast cancer and contributes to cell proliferation and invasion. However, the expression pattern and biological function of MIR31HG in gastric cancer are still not well documented. In this study, we found that MIR31HG expression is decreased in gastric cancer tissues and associated with larger tumor size and advanced pathological stage. Patients with lower MIR31HG expression had a relatively poor prognosis. Furthermore, ectopic over-expression of MIR31HG could inhibit gastric cancer (GC) cell proliferation both in vitro and in vivo, while knockdown of MIR31HG by small interfering RNA (siRNA) promoted cell proliferation in GC cells partly via regulating E2F1 and p21 expression. Our findings present that decreased MIR31HG is involved in GC development and could be identified as a poor prognostic biomarker in GC patients.

Indexed as

AnimalsCarcinomaCell DivisionCyclin-Dependent Kinase Inhibitor p21E2F1 Transcription FactorFemaleGene Expression Regulation, NeoplasticHumansKaplan-Meier EstimateMaleMice, Inbred BALB CMice, NudeMicroRNAsMiddle AgedNeoplasm ProteinsPrognosisCDKN1A protein, humanCyclin-Dependent Kinase Inhibitor p21E2F1 protein, humanE2F1 Transcription FactorMicroRNAsMIRN31 microRNA, humanNeoplasm ProteinsRecombinant Fusion ProteinsRNA, NeoplasmRNA, Small InterferingE2F1Gastric cancerLong noncoding RNAMIR31HGProliferation

Identifiers

PMID26692098
OpenAlexW2235660695

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.